Skip to main content
Amirali (Hassanzadeh Salmasi) Salmasi, MD, Urology, San Diego, CA

Amirali(Hassanzadeh Salmasi)SalmasiMDMS

Urology San Diego, CA

Surgical Oncology

Associate Professor of Urology, Urologic Oncology, UCSD

Dr. Salmasi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Salmasi's full profile

Already have an account?

  • Office

    200 W Arbor Dr
    San Diego, CA 92103
    Phone+1 800-926-8273
    Fax+1 888-539-8781

Education & Training

  • Clinical and Translational Science Institute, UCLA
    Clinical and Translational Science Institute, UCLAMSCR, 2016 - 2018
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2011 - 2015
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2009 - 2011
  • Tehran University of Medical Sciences School of Medicine
    Tehran University of Medical Sciences School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2026
  • NJ State Medical License
    NJ State Medical License 2013 - 2017
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging  
    Steven S Raman, Sohrab A Mirak, Izak Faiena, Aydin Pooli, Amirali Salmasi, Ely R Felker, European Urology
  • Radical Prostatectomy Then and Now: Surgical Overtreatment of Prostate Cancer Is Declining from 2009 to 2016 at a Tertiary Referral Center  
    Amirali Salmasi, Izak Faiena, Karim Chamie, Urologic Oncology

Authored Content

  • Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
  • Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018

Press Mentions

  • Unio Specialty Care: Advancing the Healthcare Paradigm Shift in Urology and Gastroenterology Towards Value-Based Care
    Unio Specialty Care: Advancing the Healthcare Paradigm Shift in Urology and Gastroenterology Towards Value-Based CareJuly 29th, 2024
  • Medical Moment: Using Blue Light to Identify Bladder Cancer
    Medical Moment: Using Blue Light to Identify Bladder CancerJanuary 7th, 2024
  • Gene Therapy for Bladder Cancer Enters Clinics
    Gene Therapy for Bladder Cancer Enters ClinicsJuly 10th, 2024
  • Join now to see all

Professional Memberships

Other Languages

  • Farsi